Macrophagic myofasciitis and vaccination: consequence or coincidence?
Tânia Santiago1, Olinda Rebelo, Luís Negrão
1Rheumatology Unit, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal, tlousasantiago@hotmail.com.
Macrophagic myofasciitis (MMF) is linked to aluminum-containing vaccines. This condition involves persistent aluminum hydroxide in muscle tissue, potentially triggering inflammatory myopathy in susceptible individuals.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Macrophagic myofasciitis (MMF) is a condition characterized by muscle lesions showing long-term aluminum hydroxide persistence.
- It has been increasingly reported over the last decade, often following immunization.
Purpose of the Study:
- To describe the clinical and laboratory findings in patients diagnosed with MMF.
- To investigate the potential link between aluminum-containing vaccines and MMF development.
Main Methods:
- Retrospective analysis of 16 MMF cases observed between January 2000 and July 2013.
- Review of clinical data, laboratory results, and electromyogram findings.
Main Results:
- The average patient age was 48.8 years, with 80% being female.
- Chronic fatigue syndrome was present in 8 patients; 50% had elevated creatinine kinase.
- 25% showed myopathic electromyograms, and 13 patients had received aluminum-containing vaccines prior to symptom onset.
Conclusions:
- MMF presents as a distinct pattern of inflammatory myopathy.
- Aluminum-containing vaccines may act as a trigger for MMF in certain individuals.
More Related Videos
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
Related Concept Videos
Vaccinations
Myasthenia Gravis ll: Pathophysiology
Myocarditis I: Introduction
Cross-reactivity
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Rheumatic Heart Disease I: Introduction
